Export

Meropenem
Essential medicine status
Section:
6. Anti-infective medicines 6.2. Antibacterials 6.2.5. Antituberculosis medicines
ATC codes: J01DH02
EMLc
Indication
Multi-drug resistant Mycobacterium tuberculosis ICD11 code: ML32.00
INN
Meropenem
Medicine type
Chemical agent
Antibiotic groups
WATCH
List type
Complementary
Additional notes
The square box applies only to the listing of meropenem on the EML.
Formulations
Parenteral > General injections > IV: 500 mg in vial (as trihydrate) powder for injection ; 1 g in vial (as trihydrate) powder for injection
EML status history
First added in 2019 (TRS 1021)
Changed in 2021 (TRS 1035)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
imipenem + cilastatin (ATC codes: J01DH51)
Patent information
Patents have expired in most jurisdictions
Wikipedia
Meropenem
DrugBank
Meropenem
Summary of evidence and Expert Committee recommendations
Following the review of square box listings on the EML and EMLc, the Expert Committee recommended imipenem + cilastatin be specified as a therapeutic alternative under the square box listing for meropenem on the EML for this indication.